230 related articles for article (PubMed ID: 33940114)
21. Summary of the 2018 Kidney Disease Improving Global Outcomes (KDIGO) Guideline on hepatitis C in chronic kidney disease.
Gordon CE; Balk EM; Francis JM
Semin Dial; 2019 Mar; 32(2):187-195. PubMed ID: 30496617
[TBL] [Abstract][Full Text] [Related]
22. Challenges of transferring rural adults with chronic HCV infection for further HCV RNA confirmation and free DAAs treatment: a success story of the interdisciplinary collaboration approach.
Li W; Chang TS; Chang SZ; Chen CH; Chen MY
BMC Infect Dis; 2020 Oct; 20(1):737. PubMed ID: 33028228
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.
Li T; Qu Y; Guo Y; Wang Y; Wang L
Liver Int; 2017 Jul; 37(7):974-981. PubMed ID: 27943605
[TBL] [Abstract][Full Text] [Related]
24. Antiviral treatment and prognosis in patients undergoing maintenance hemodialysis due to hepatitis C virus.
Zhang W; Yuan Q; Ning J; Li X; Wu A; Xiao X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1332-1337. PubMed ID: 35232901
[TBL] [Abstract][Full Text] [Related]
25. Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study.
Singer AW; Reddy KR; Telep LE; Osinusi AO; Brainard DM; Buti M; Chokkalingam AP
Aliment Pharmacol Ther; 2018 May; 47(9):1278-1287. PubMed ID: 29516535
[TBL] [Abstract][Full Text] [Related]
26. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
27. An Investigation of the Side Effects, Patient Feedback, and Physiological Changes Associated with Direct-Acting Antiviral Therapy for Hepatitis C.
Wu PS; Chang TS; Lu SN; Su HJ; Chang SZ; Hsu CW; Chen MY
Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31817863
[No Abstract] [Full Text] [Related]
28. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
29. Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.
Sawinski D; Forde KA; Lo Re V; Goldberg DS; Cohen JB; Locke JE; Bloom RD; Brensinger C; Weldon J; Shults J; Reese PP
Am J Kidney Dis; 2019 Jun; 73(6):815-826. PubMed ID: 30704882
[TBL] [Abstract][Full Text] [Related]
30. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.
Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ
Liver Int; 2019 Dec; 39(12):2261-2272. PubMed ID: 31444846
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia.
Stvilia K; Vephkvadze N; Gamkrelidze A; Khonelidze I; Getia V; Tsereteli M; Gvinjilia L; Kuchuloria T
Public Health; 2021 Jun; 195():42-50. PubMed ID: 34051674
[TBL] [Abstract][Full Text] [Related]
32. Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories.
Mendizabal M; Reddy KR
J Viral Hepat; 2017 Jun; 24(6):442-453. PubMed ID: 28107583
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus infection in maintenance hemodialysis patients: recommendations for diagnostics and treatment.
Dzekova-Vidimliski P; Sikole A
Int J Artif Organs; 2017 Feb; 39(12):590-595. PubMed ID: 28165585
[TBL] [Abstract][Full Text] [Related]
34. Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a Breakthrough project: a mixed method study.
Kracht PAM; de Gee EA; van der Poel A; Verhagen MAMT; Hoepelman AIM; Croes EA; Arends JE
Harm Reduct J; 2019 Jul; 16(1):45. PubMed ID: 31307470
[TBL] [Abstract][Full Text] [Related]
35. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
[TBL] [Abstract][Full Text] [Related]
36. Male Sexual Dysfunction Among Egyptian Patients with Chronic Hepatitis C Virus Infection Before and After Direct-Acting Antiviral Drugs.
Elshimi E; Morad W; Mohamad NE
J Sex Med; 2019 Mar; 16(3):402-409. PubMed ID: 30846113
[TBL] [Abstract][Full Text] [Related]
37. Developing a multidisciplinary HCV direct-acting antivirals utilization management and assessment program.
Ajlan AA; Al-Gain R; Ahmed M; Abu-Riash T; Alquaiz M; Alkhail FA; Alashgar H; Alkhairallah T; Alkortas D; Al-Jedai A
J Am Pharm Assoc (2003); 2021; 61(2):e159-e170. PubMed ID: 33309191
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.
Kim SM; Song IH
Korean J Intern Med; 2018 Jul; 33(4):670-678. PubMed ID: 29961309
[TBL] [Abstract][Full Text] [Related]
39. French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long.
Brouard C; Pillonel J; Boussac M; de Lédinghen V; Rachas A; Silvain C; Lydié N; Chevaliez S; Pioche C; Durand J; Lot F; Delarocque-Astagneau E
BMC Infect Dis; 2020 Oct; 20(1):759. PubMed ID: 33059617
[TBL] [Abstract][Full Text] [Related]
40. Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study.
Chen Q; Ayer T; Bethea E; Kanwal F; Wang X; Roberts M; Zhuo Y; Fagiuoli S; Petersen J; Chhatwal J
BMJ Open; 2019 Jun; 9(6):e026726. PubMed ID: 31189677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
